Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis

Journal of Autoimmunity

Volumn 76, Issue , 2017, Pages 108-114

  Paterka, Magdalena ^a   Voss, Jan Oliver ^b   Werr, Johannes ^b   Reuter, Eva ^a   Franck, Sophia ^a   Leuenberger, Tina ^b   Herz, Josephine ^b   Radbruch, Helena ^b   Bopp, Tobias ^a   Siffrin, Volker ^a   Zipp, Frauke ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Dendritic cells; EAE; Immune regulation; Multiple sclerosis; Th17; Treg cells

Indexed keywords

INTERLEUKIN 2; CYTOKINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CELL REGENERATION; DENDRITIC CELL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; ANIMAL; AUTOIMMUNITY; IMMUNOLOGY; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; AUTOIMMUNITY; CYTOKINES; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84994469312     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2016.09.008     Document Type: Article

References (38)

1. [1] Steinman, R.M., Banchereau, J., Taking dendritic cells into medicine. Nature 449 (2007), 419–426.
2. [2] Greter, M., Heppner, F.L., Lemos, M.P., Odermatt, B.M., Goebels, N., Laufer, T., et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11 (2005), 328–334.
3. [3] Paterka, M., Siffrin, V., Voss, J.O., Werr, J., Hoppmann, N., Gollan, R., et al. Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation. EMBO J. 35 (2016), 89–101.
4. [4] Karman, J., Chu, H.H., Co, D.O., Seroogy, C.M., Sandor, M., Fabry, Z., Dendritic cells amplify T cell-mediated immune responses in the central nervous system. J. Immunol. 177 (2006), 7750–7760.
5. [5] McMahon, E.J., Bailey, S.L., Castenada, C.V., Waldner, H., Miller, S.D., Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11 (2005), 335–339.
6. [6] Menges, M., Rossner, S., Voigtlander, C., Schindler, H., Kukutsch, N.A., Bogdan, C., et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195 (2002), 15–21.
7. [7] Legge, K.L., Gregg, R.K., Maldonado-Lopez, R., Li, L., Caprio, J.C., Moser, M., et al. On the role of dendritic cells in peripheral T cell tolerance and modulation of autoimmunity. J. Exp. Med. 196 (2002), 217–227.
8. [8] Li, H., Zhang, G.X., Chen, Y., Xu, H., Fitzgerald, D.C., Zhao, Z., et al. CD11c+CD11b+ dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis. J. Immunol. 181 (2008), 2483–2493.
9. [9] Oldenhove, G., Bouladoux, N., Wohlfert, E.A., Hall, J.A., Chou, D., Dos Santos, L., et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31 (2009), 772–786.
10. [10] Chen, W., Jin, W., Hardegen, N., Lei, K.J., Li, L., Marinos, N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003), 1875–1886.
11. [11] Jung, S., Unutmaz, D., Wong, P., Sano, G., De los Santos, K., Sparwasser, T., et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17 (2002), 211–220.
12. [12] Bettelli, E., Pagany, M., Weiner, H.L., Linington, C., Sobel, R.A., Kuchroo, V.K., Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197 (2003), 1073–1081.
13. [13] Esplugues, E., Huber, S., Gagliani, N., Hauser, A.E., Town, T., Wan, Y.Y., et al. Control of TH17 cells occurs in the small intestine. Nature 475 (2011), 514–518.
14. [14] Siffrin, V., Brandt, A.U., Radbruch, H., Herz, J., Boldakowa, N., Leuenberger, T., et al. Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization. Brain 132 (2009), 1247–1258.
15. [15] Zaft, T., Sapoznikov, A., Krauthgamer, R., Littman, D.R., Jung, S., CD11chigh dendritic cell ablation impairs lymphopenia-driven proliferation of naive and memory CD8+ T cells. J. Immunol. 175 (2005), 6428–6435.
16. [16] Sapoznikov, A., Fischer, J.A., Zaft, T., Krauthgamer, R., Dzionek, A., Jung, S., Organ-dependent in vivo priming of naive CD4+, but not CD8+, T cells by plasmacytoid dendritic cells. J. Exp. Med. 204 (2007), 1923–1933.
17. [17] Kohm, A.P., Carpentier, P.A., Anger, H.A., Miller, S.D., Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169 (2002), 4712–4716.
18. [18] Targoni, O.S., Baus, J., Hofstetter, H.H., Hesse, M.D., Karulin, A.Y., Boehm, B.O., et al. Frequencies of neuroantigen-specific T cells in the central nervous system versus the immune periphery during the course of experimental allergic encephalomyelitis. J. Immunol. 166 (2001), 4757–4764.
19. [19] Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T.R., et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13 (2007), 423–431.
20. [20] Curotto de Lafaille, M.A., Kutchukhidze, N., Shen, S., Ding, Y., Yee, H., Lafaille, J.J., Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29 (2008), 114–126.
21. [21] Irla, M., Kupfer, N., Suter, T., Lissilaa, R., Benkhoucha, M., Skupsky, J., et al. MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity. J. Exp. Med. 207 (2010), 1891–1905.
22. [22] Herz, J., Paterka, M., Niesner, R.A., Brandt, A.U., Siffrin, V., Leuenberger, T., et al. In vivo imaging of lymphocytes in the CNS reveals different behaviour of naive T cells in health and autoimmunity. J. Neuroinflam., 8, 2011, 131.
23. [23] Langrish, C.L., Chen, Y., Blumenschein, W.M., Mattson, J., Basham, B., Sedgwick, J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201 (2005), 233–240.
24. [24] Prod'homme, T., Weber, M.S., Zamvil, S.S., T effectors outfox T regulators in autoimmunity. Nat. Med. 13 (2007), 411–413.
25. [25] Steinman, R.M., Nussenzweig, M.C., Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. U S A 99 (2002), 351–358.
26. [26] Birnberg, T., Bar-On, L., Sapoznikov, A., Caton, M.L., Cervantes-Barragan, L., Makia, D., et al. Lack of conventional dendritic cells is compatible with normal development and T cell homeostasis, but causes myeloid proliferative syndrome. Immunity 29 (2008), 986–997.
27. [27] Ohnmacht, C., Pullner, A., King, S.B., Drexler, I., Meier, S., Brocker, T., et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 206 (2009), 549–559.
28. [28] Bar-On, L., Birnberg, T., Kim, K.W., Jung, S., Dendritic cell-restricted CD80/86 deficiency results in peripheral regulatory T-cell reduction but is not associated with lymphocyte hyperactivation. Eur. J. Immunol. 41 (2011), 291–298.
29. [29] Yogev, N., Frommer, F., Lukas, D., Kautz-Neu, K., Karram, K., Ielo, D., et al. Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells. Immunity 37 (2012), 264–275.
30. [30] Lin, C.H., Hunig, T., Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur. J. Immunol. 33 (2003), 626–638.
31. [31] Tischner, D., Weishaupt, A., van den Brandt, J., Muller, N., Beyersdorf, N., Ip, C.W., et al. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis. Brain 129 (2006), 2635–2647.
32. [32] Beyersdorf, N., Gaupp, S., Balbach, K., Schmidt, J., Toyka, K.V., Lin, C.H., et al. Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis. J. Exp. Med. 202 (2005), 445–455.
33. [33] Godfrey, W.R., Ge, Y.G., Spoden, D.J., Levine, B.L., June, C.H., Blazar, B.R., et al. In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104 (2004), 453–461.
34. [34] Hauser, S.L., Waubant, E., Arnold, D.L., Vollmer, T., Antel, J., Fox, R.J., et al. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358 (2008), 676–688.
35. [35] Piccio, L., Naismith, R.T., Trinkaus, K., Klein, R.S., Parks, B.J., Lyons, J.A., et al. Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. Arch. Neurol. 67 (2010), 707–714.
36. [36] Weber, M.S., Prod'homme, T., Patarroyo, J.C., Molnarfi, N., Karnezis, T., Lehmann-Horn, K., et al. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity. Ann. Neurol. 68 (2010), 369–383.
37. [37] Hofstetter, H.H., Toyka, K.V., Tary-Lehmann, M., Lehmann, P.V., Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice. J. Immunol. 178 (2007), 1372–1378.
38. [38] Ivanov II, McKenzie, B.S., Zhou, L., Tadokoro, C.E., Lepelley, A., Lafaille, J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 (2006), 1121–1133.